PETALING JAYA: TMC Life Sciences Bhd
expects a continued recovery in the healthcare sector and is cautiously optimistic of its mid to long-term growth despite the predicted wave of Omicron infections in Malaysia.
In a filing with Bursa Malaysia, the healthcare group said its new facilities at Thomson Hospital Kota Damansara is targeted to begin operations in the third quarter of financial year ending June 30, 2022, which would add significant capacity to the hospital.
